Congenital Heart Disease
Conditions
Brief summary
To compare safety, efficacy and procedural outcome of percutaneous PDA closure using different approaches for better characterization of device selection criteria.
Interventions
transcatheter patent ductus arteriosus closure
Sponsors
Study design
Eligibility
Inclusion criteria
* all patients who are candidate for transcatheter PDA closure
Exclusion criteria
1. Patients with PDA dependent pulmonary circulation. 2. Patients with small sized PDA which is silent by auscultation 3. Patients with large sized PDA which is unsuitable for Trans-catheter closure 4. Patients with PDA and severe irreversible pulmonary hypertension (Eisenmenger's syndrome) (7). 5. Patients with active infection or active infective endarteritis. 6. Patients refusing the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Procedural safety | one month | studying the occurrence of catheter related complications including 1. Occurrence of vascular access hematoma(Yes/No ) 2. Occurrence of contrast induced nephropathy (Yes/No) 3. PDA closure Device embolization (Yes/No) 4. Cardiac tamponade (Yes/No) |
| Procedural efficacy | one month | timing of complete closure of the PDA with no residual shunts 1. Residual left to right shunt (Yes/No) 2. Degree of the residual shunt (Trace, Mild , Moderate, severe) 3. Timing of closure of the shunt( immediately postprocedural, 24 hours post procedural , 1 month post procedural ) |
| Procedural outcomes | one month | comparison of echocardiography data that will be done pre catheter closure, one day post procedure and one month later ( left ventricular and atrial dimensions-left ventricular ejection fraction-pulmonary artery systolic pressure- degree of tricuspid regurge) |